On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals, though skepticism remains.

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

Revolution Medicines, Inc. (NASDAQ:RVMD) has been making waves in the biotechnology sector with its innovative approach to ...

This study presents a valuable finding on the role of secretory leukocyte protease inhibitors (SLPI) in developing Lyme disease in mice infected with Borrelia burgdorferi. The evidence supporting the ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ability to invade human cells. SARS-CoV-2 is the virus that spreads COVID-19.

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on BBIO stock, giving a Buy rating yesterday.Stay Ahead of the ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ...

A recent study evaluates the potential of Nanosota-EB1 and Nanosota-EB2, nanobody inhibitors targeting the Ebola virus.

You should read the following information carefully as it will help you determine whether you meet our entry requirements. You should also read the 'Entry Requirements' and 'Assessing your application ...

Geode Capital Management LLC lessened its holdings in Assembly Biosciences, Inc. (NASDAQ:ASMB – Free Report) by 13.6% in the third quarter, Holdings Channel reports. The institutional investor owned ...

Nuvalent's NVL-655 and Zidesamtinib show strong potential as first-line therapies for NSCLC. Click here to find out why I ...